Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 9,466 |
|
|||||
| News | - | ||||||
| Day High | 2.52 | Low High |
|||||
| Day Low | 2.3401 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| OpGen Inc | OPGN | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.01 | 0.40% | 2.50 | 23:00:10 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.45 | 2.3401 | 2.52 | 2.50 | 2.49 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 438 | 9,466 | US$ 2.42 | US$ 22,942 | - | 1.65 - 38.40 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:30:24 | 13 | US$ 2.37 | USD |
OpGen Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 25.23M | 10.01M | - | 3.42M | -32.67M | -3.26 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
OpGen News
| Date | Time | Source | News Article |
|---|---|---|---|
| 6/11/2024 | 15:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 6/03/2024 | 15:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 5/30/2024 | 15:30 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] |
| 5/24/2024 | 15:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 5/24/2024 | 15:05 | GlobeNewswire Inc. | OpGen Receives Expected Nasdaq Notice Regarding Delayed Form.. |
| 5/22/2024 | 15:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 5/17/2024 | 16:02 | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form.. |
| 5/16/2024 | 06:00 | GlobeNewswire Inc. | OpGen Announced 1-for-10 Reverse Stock Split |
| 5/14/2024 | 15:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 4/29/2024 | 15:05 | GlobeNewswire Inc. | OpGen Provides Update on Business Operations and Strategic.. |
| 4/23/2024 | 15:15 | GlobeNewswire Inc. | OpGen Receives Nasdaq Notice Regarding Delayed Form 10-K |
| 3/26/2024 | 15:20 | AllPennyStocks.com | Shares Rip In Reaction To Activist Investor Becoming CEO |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical OPGN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.64 | 2.725 | 2.3401 | 2.55 | 20,197 | -0.14 | -5.30% |
| 1 Month | 4.883 | 5.30 | 2.3401 | 3.90 | 85,656 | -2.38 | -48.80% |
| 3 Months | 5.093 | 9.90 | 2.3401 | 7.06 | 1,812,343 | -2.59 | -50.91% |
| 6 Months | 3.75 | 9.90 | 2.3401 | 6.73 | 946,623 | -1.25 | -33.33% |
| 1 Year | 6.60 | 38.40 | 1.65 | 6.62 | 1,697,441 | -4.10 | -62.12% |
| 3 Years | 430.00 | 744.00 | 1.65 | 134.97 | 1,469,863 | -427.50 | -99.42% |
| 5 Years | 86.46 | 2,560.00 | 1.65 | 383.77 | 2,116,823 | -83.96 | -97.11% |
OpGen Description
| OpGen Inc is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It is developing molecular information products and services for healthcare settings, helping to guide clinicians with rapid and actionable information about life-threatening infections, improve patient outcomes, and decrease the spread of infections caused by MDROs. Its proprietary DNA tests and informatics address the rising threat of antibiotic resistance by helping physicians and other healthcare providers optimize care decisions for patients with acute infections. The company's product candidates and services combine its Acuitas molecular diagnostics and Acuitas Lighthouse informatics platform for use with its curated MDRO knowledge base. |
